Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune rheumatic disease of unknown etiology which manifests itself in chronic erosive arthritis (synovitis) and systemic lesions affecting internal organs. The main emphasis in the RA treatment is placed on the pharmacological therapy: non-steroidal anti-inflamma...
Main Authors: | D. V. Goryachev, M. Yu Telnykh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEICON ISP LLC
2018-12-01
|
Series: | Ведомости Научного центра экспертизы средств медицинского применения |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/196 |
Similar Items
-
STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION
by: M. A. Kotovskaya, et al.
Published: (2018-03-01) -
ADHERENCE OF THE PATIENTS WITH RHEUMATOID ARTHRITIS TO BASE ANTI-INFLAMMATORY TREATMENT
by: R. R. Akhunova, et al.
Published: (2014-07-01) -
ADHERENCE OF THE PATIENTS WITH RHEUMATOID ARTHRITIS TO BASE ANTI-INFLAMMATORY TREATMENT
by: R. R. Akhunova, et al.
Published: (2014-07-01) -
Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome
by: Chung‐Yuan Hsu, et al.
Published: (2021-04-01) -
The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis
by: A. S. Avdeeva, et al.
Published: (2016-10-01)